Latest Regulatory Clearance News

Hastings Technology Metals has signed a binding agreement to sell its gold assets to Metal Bank Limited in a share-and-cash deal, marking a strategic pivot towards rare earths and niobium development.

Race Oncology has secured Investigational New Drug approval from South Korea’s regulatory authority, enabling Phase 1 clinical trials of RC220 in combination with doxorubicin for solid tumour patients across four Korean sites.

Amplitude Energy is expanding its East Coast Supply Project by adding a fourth well at the Nestor prospect and plans a potential restart of the Patricia Baleen field, supported by a $150 million equity raising to fund these growth initiatives.

Shriro Holdings has reversed its plan to delist from the ASX and scrap a $5 million share buy-back, now considering a special dividend to reward shareholders.

Peak Rare Earths has postponed its critical court hearing for Shenghe Resources' acquisition scheme due to a delay in Tanzanian regulatory approval, pushing the decision to 19 September 2025.

Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.

Mad Paws Holdings Limited (ASX – MPA) shareholders are invited to vote on a Scheme of Arrangement for the acquisition of 100% of Mad Paws by Rover Group, Inc. at $0.14 cash per share. The Mad Paws Board unanimously recommends approval, supported by an Independent Expert’s Report deeming the deal fair and reasonable.

Peak Rare Earths Limited shareholders are set to vote on Shenghe Resources’ $195 million acquisition offer, which includes a 32% premium over recent share prices. Despite a higher unsolicited bid from GICP, the board recommends accepting Shenghe’s proposal.

Metal Bank Limited has completed due diligence on Hastings Technology Metals' gold assets and is set to commence drilling at the Seven Leaders prospect, marking a key step in its Western Australian gold expansion strategy.

Peak Rare Earths Limited held a pivotal scheme meeting on 16 September 2025 to approve Shenghe Resources’ $195 million acquisition offer, which includes a 23% premium on the original proposal. Despite a higher unsolicited bid, the board recommends shareholders back Shenghe’s cash deal.

Renergen Limited and ASP Isotopes Inc. have proactively extended the deadline to fulfill outstanding conditions for their Scheme of Arrangement offer to 28 November 2025, following key regulatory approvals and ongoing collaboration.

AVITA Medical has secured the CE Mark for its innovative RECELL GO device, paving the way for commercialization across key European markets including Germany, Italy, and the UK. This regulatory milestone expands the company’s footprint in acute wound care.